Companies / Israel
R&D Law Reform Raises Hopes For Biotech
September 2006 | Legal NewsIsraeli legal experts have highlighted recent amendments to the country's 'R&D Law', which are expected to ease the transfer of technologies abroad. It is hoped that the reforms will enable know-how that has been partly funded by the Office of the Chief Scientist (OCS) to be transferred to foreign firms, with a positive impact for knowledge-intensive industries such as
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
